Breast Reconstruction - Market Insights, Competitive Landscape, and Market Forecast - 2030

Breast Reconstruction Market By Product Type (Breast Implants, Breast Expanders, And Acellular Dermal Matrix), By Shape (Round And Anatomical), By End-User (Hospitals, Cosmetology Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of breast cancer and the increase in the number of cosmetic & reconstructive plastic surgeries

The global breast reconstruction market was valued at USD 554.50 million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 810.14 million by 2030. The breast reconstruction market is witnessing positive growth owing to various factors such as the increasing prevalence of breast cancer, the increase in the number of cosmetic & reconstructive surgeries, the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity drives the breast reconstruction demand. Therefore, the market for breast reconstruction is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Breast Reconstruction Market Dynamics:

One of the main drivers of the breast reconstruction market is the increasing prevalence of breast cancer globally. According to World Health Organization (WHO) data published in the year 2023, 2.3 million women worldwide were diagnosed with breast cancer in 2020. As per the same source mentioned above, by the end of 2020, 7.8 million women were diagnosed with breast cancer in the previous five years, making it the most common disease in the world.

Moreover, another key factor that is responsible for the growth of the breast reconstruction market is the increase in the number of cosmetic & reconstructive surgeries across the globe. For instance, according to the plastic surgery statistics report 2020, in America, there were 15.6 million total cosmetic procedures performed in the year 2020, of which 2.3 million were cosmetic surgical procedures and 13.2 million cosmetic procedures were minimally invasive. As per the same source, 6.8 million reconstructive procedures were performed in the year 2020 (a 3% increase from 2019). Further, in the year 2020, in America, there were 193,073 breast augmentations performed, of which silicone implants were utilized in 84% while saline implants were used in 16%. Therefore, with the increase in cosmetic & reconstructive surgeries, demand for breast reconstruction also increases, thereby driving the breast reconstruction overall market growth.

Therefore, all the factors mentioned above will collectively surge the overall growth of the breast reconstruction market during the forecast period from 2024-2030.

However, availability of the alternative non-surgical methods and the high cost of breast reconstruction using implants will hamper the global breast reconstruction market growth.

The ongoing Coronavirus disease 2019 (COVID-19) pandemic has negatively impacted the market for breast reconstruction as hospital admissions for patients suffering from cancers & other disorders as well as elective surgeries were not a priority in comparison to the patients suffering from COVID. Lockdown restrictions, lack of staff, and shortage of masks, and PPE kits made a huge impact on patient admissions in hospitals for breast reconstruction. However, with masses being vaccinated, lockdown restriction relaxation, resumption of elective surgeries, and availability of masks, PPE kits, and staff, the breast reconstruction market has picked momentum and is expected to grow during the forecast period from 2024-2030.

Breast Reconstruction Market Segment Analysis:

Breast Reconstruction Market by Product Type (Breast Implants, Breast Expanders, and Acellular Dermal Matrix), Shape (Round and Anatomical), End-User (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the by-product type segment of the breast reconstruction market, breast implants are expected to hold a significant revenue share in the year 2023. The key attributes driving the growth of the breast reconstruction market includes the rising demand of breast implants among the women across the globe as to enhance their aesthetic appeal. Breast reconstructive surgery address congenital defects and deformities of the chest wall, it is also used to change shape as well as size of the breast. Further, breast reconstructive surgery also helps to restore a natural-looking breast following a mastectomy, or simply to enlarge the breasts and it's a good alternative for people who don't have a lot of fatty tissue on breast, and adds volume as well as curves to the breast.

Therefore, the benefits associated with breast implants for breast reconstruction would increase their demand in the market, which will drive the growth of the overall breast reconstruction market during the forecast period. Further, the increase in the regulatory approvals for breast reconstruction products is also driving market growth. For instance, in September 2020, Mentor Worldwide LLC, the world's leading breast aesthetics company and a subsidiary of Johnson & Johnson Medical Devices, announced that the US Food and Drug Administration (FDA) has approved the MENTOR® MemoryGel BOOSTTM breast implant for breast augmentation in women over the age of 22 and for breast reconstruction in women of all ages.

Therefore, such type of development activities in the breast implant segment for breast reconstruction would result in driving the demand for breast reconstruction which in turn would provide a conductive growth for the overall breast reconstruction market during the forecast 2024-2030.

North America is expected to dominate the overall Breast Reconstruction Market:

Among all the regions, North America is expected to dominate the global breast reconstruction market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as aging, race, and ethnicity drive breast reconstruction demand, and the surge in the launch of technologically advanced breast reconstruction products are expected to increase the demand for breast reconstructions in the North America market.

According to the American Cancer Society data published in January 2022, breast cancer rates vary between racial and ethnic groupings in the United States. According to the latest statistics, black women are diagnosed at a younger age (60) than white women (63), and they have a higher death rate. This might be because one in every five black women has triple-negative breast cancer, which is greater than any other racial/ethnic group. As per the source mentioned above, black women have a significant risk of having cancer before the age of 40 years.

Furthermore, the most significant risk factor for breast cancer is age. People's risks of having cancer increase as they grow older. According to the American Cancer Society, data published in the year 2023, in the United States, one out of every eight women under the age of 45 will acquire invasive breast cancer by the end of the year 2022, and two out of every three invasive breast cancers will be diagnosed in women 55 and older.

Moreover, according to the Breast Cancer Organization data published in the year 2023, more than 3.8 million women in the United States had a history of breast cancer as of January 2022. As per the aforementioned source, by the end of the year 2022, 2,710 additional instances of invasive breast cancer in men are predicted to be detected.

Additionally, another factor such as the surge in the launch of technologically advanced breast reconstruction products will also drive the breast reconstruction market. For instance, in May 2022, GC Aesthetics Inc., a privately-held medical technology company providing aesthetic solutions, announced the launch of its next-generation breast implants, PERLE(TM). It is a highly innovative line of smooth breast implants that features a proprietary surface technology (BioQ(TM)), GCA's industry-leading gel technology (Emunomic(TM) Breast Tissue Dynamic Gel), and an improved version of the safety measures that have underpinned GCA's long-term excellent safety record.

Therefore, the interplay of the factors mentioned above for breast reconstruction would provide a conducive growth environment for the North American region in the breast reconstruction market.

Breast Reconstruction Market Key Players:

Some of the key market players operating in the breast reconstruction market include Mentor Worldwide LLC, AbbVie Inc, IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra Inc, Integra LifeSciences, Establishment Labs S.A, LABORATOIRES ARION, HansBioMed, Lattice Medical, CEREPLAS, AirXpanders, PMT Corporation, SILIMED, DPS Technology Development Ltd, Technomed (India) Private Limited, Apex Medical Device Design LLC (DefyGravity), Guangzhou Wanhe Plastic Material Co Ltd and among others

Recent Developmental Activities in the Breast Reconstruction:

In September 2020, POLYTECH Health & Aesthetics GmbH, a global pioneer in breast aesthetics, expanded its B-Lite® portfolio, which includes the world's first and only lightweight breast implants. B-Lite® breast implants offer several benefits to women, including faster recovery & less post-operative discomfort, allowing patients to return to their normal routine sooner. B-Lite® with MESMO® fine-texturing surface and B-Lite® with the distinctive Microthane® shell coating are among the new forms and surfaces in the enlarged offering

In August 2020, Sientra, Inc, a diversified global medical aesthetics company, announced the approval from Japan's Pharmaceutical and Medical Device Agency ("PDMA") to market its entire OPUS line of breast implants in Japan.

In November 2019, BellaSano, German additive manufacturing start-up signed a long term agreement with Evonik, a chemical company's RESOMER bioresorbable polymer to create a new breast implant technology. RESOMER will be used in BellaSeno's 3D-printed Senella breast scaffold. The product is intended to be used for breast reconstruction, augmentation, and revision surgery. As it is gradually absorbed by the body and the natural breast tissue replaces it.

Key Takeaways from the Breast Reconstruction Market Report Study:

• Market size analysis for the current breast reconstruction market (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the breast reconstruction market
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint venture happened for last 3 years
• Key companies dominating the global breast reconstruction
• Various opportunities available for the other competitor in the breast reconstruction market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current breast reconstruction market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for breast reconstruction market growth in the coming future?

Target Audience who can be benefited from this Breast Reconstruction Market Report Study

• Breast reconstruction providers
• Research organizations and consulting companies
• Breast reconstruction-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in breast reconstruction
• Various end-users who want to know more about the breast reconstruction market and latest technological developments in the breast reconstruction

Frequently Asked Questions for Breast Reconstruction:

1. What is Breast Reconstruction?

Breast reconstruction is a surgical procedure that reconstructs the form and appearance of a breast, most often in women who have had breast cancer surgery. The objective is to rebuild a natural-looking breast utilizing autologous tissue, artificial implants, or a mix of both.

2. What is the market for Global Breast Reconstruction?

The global breast reconstruction market was valued at USD 554.50 million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 810.14 million by 2030.

3. What are the drivers for the Global Breast Reconstruction market?

The breast reconstruction market is witnessing positive market growth owing to the factors such as, such as the increasing prevalence of breast cancer, the increase in the number of cosmetic & reconstructive surgeries, the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity will also contribute in the growth of breast cancer which drives the breast reconstruction product demand.

4. Who are the key players operating in the Breast Reconstruction market?

Some of the key market players operating in the breast reconstruction market include Mentor Worldwide LLC, AbbVie Inc, IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra Inc, Integra LifeSciences, Establishment Labs S.A, LABORATOIRES ARION, HansBioMed, Lattice Medical, CEREPLAS, AirXpanders, PMT Corporation, SILIMED, DPS Technology Development Ltd, Technomed (India) Private Limited, Apex Medical Device Design LLC (DefyGravity), Guangzhou Wanhe Plastic Material Co Ltd and among others.

5. Which region has the highest share in Breast Reconstruction Market?

North America is expected to dominate the global breast reconstruction market. Factors contributing to the growth are the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity drive the breast reconstruction demand, contributes to the growth of the breast reconstruction market in the North America region.